Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein : LP-AI and LP-AI/AIIJOHNSON, W. J; KILSDONK, E. P. C; VAN TOL, A et al.Journal of lipid research. 1991, Vol 32, Num 12, pp 1993-2000, issn 0022-2275Article

Relationship between post-heparin plasma lipases, triglycerides and high density lipoproteins in normal subjectsJACKSON, R. L; YATES, M. T; MCNERNEY, A et al.Hormone and metabolic research. 1990, Vol 22, Num 5, pp 289-294, issn 0018-5043Article

The measurement of high density lipoprotein subfractions in patients with primary gout using a simple precipitation methodFERNS, G. A. A; LANHAM, J; STOCKS, J et al.Annals of clinical biochemistry. 1985, Vol 22, Num 5, pp 526-532, issn 0004-5632Article

High density lipoprotein: it's not just about lipid transport anymoreGORDON, Scott M; HOFMANN, Susanna; ASKEW, David S et al.Trends in endocrinology and metabolism. 2011, Vol 22, Num 1, pp 9-15, issn 1043-2760, 7 p.Article

Studies on mechanisms for enhanced clearance of low-density lipoproteins in patients with primary hypertriglyceridaemiaVEGA, G. L; GRUNDY, S. M.Journal of internal medicine. 1989, Vol 226, Num 1, pp 5-15, issn 0954-6820, 11 p.Article

Regulation by high density lipoproteins of muscarinic acetylcholine receptor function in chick heart cells cultured in defined mediumSUBERS, E. M; NATHANSON, N. M.The Journal of biological chemistry (Print). 1989, Vol 264, Num 33, pp 19685-19693, issn 0021-9258, 9 p.Article

Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDLROMEO, Stefano; PENNACCHIO, Len A; YUNXIN FU et al.Nature genetics. 2007, Vol 39, Num 4, pp 513-516, issn 1061-4036, 4 p.Article

The effect of etophylline clofibrate on HDL subfractionsHABERBOSCH, W; GNASSO, A; ZIEGLER, W et al.Atherosclerosis. 1985, Vol 55, Num 1, pp 71-80, issn 0021-9150Article

High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the ParadigmTUTEJA, S; RADER, D. J.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 1, pp 48-56, issn 0009-9236, 9 p.Article

Inhibition of platelet function by high-density lipoprotein from a patient with apolipoprotein E deficiencyHIGASHIRA, M; KINOSHITA, M; KUME, S et al.Biochemical and biophysical research communications (Print). 1991, Vol 181, Num 3, pp 1331-1336, issn 0006-291XArticle

Genetics of the quantitative Lp(a) lipoprotein trait. III: Contribution of Lp(a) glycoprotein phenotypes to normal lipid variationBOERWINKLE, E; MENZEL, H. J; KRAFT, H. G et al.Human genetics. 1989, Vol 82, Num 1, pp 73-78, issn 0340-6717, 6 p.Article

A spin-label study on human high density lipoproteinKANASHIRO, M; MIURA, R; YAMANO, T et al.Journal of biochemistry (Tokyo). 1985, Vol 97, Num 3, pp 935-945, issn 0021-924XArticle

Change in composition of high density lipoprotein during gemfibrozil therapySORISKY, A; OOI, T. C; SIMO, I. E et al.Atherosclerosis. 1987, Vol 67, Num 2-3, pp 181-189, issn 0021-9150Article

Relationship between lipoproteins including HDL subfractions and the intravenous fat tolerance testROSSNER, S; KIRSTEIN, P.Atherosclerosis. 1984, Vol 52, Num 3, pp 287-294, issn 0021-9150Article

Lipids and cardiovascular disease 2: HDL and cardiovascular diseaseRADER, Daniel J; HOVINGH, G. Kees.Lancet (British edition). 2014, Vol 384, Num 9943, pp 618-625, issn 0140-6736, 8 p.Article

DAL OUTCOMES: Augmentation du HDL de 30 % avec un inhibiteur de la CETP: aucun effet sur le risque cardiovasculaireCardiologie cardinale. 2012, Vol 6, Num 52, issn 1960-1646, p. 234Conference Paper

Novel Targets that Affect High-Density Lipoprotein Metabolism: The Next FrontierDAVIDSON, Michael H; ROSENSON, Robert S.The American journal of cardiology. 2009, Vol 104, Num 10A, issn 0002-9149, 52E-57E, SUPArticle

Lipoprotéines contenant l'apolipoproténe A-I et transport reverse du cholestérol = Lipoproteins containing apolipoprotein A-I and reverse cholesterol transportFRUCHART, J.-C.Annales pharmaceutiques françaises. 1994, Vol 52, Num 3, pp 117-123, issn 0003-4509Article

Influence of dietary lipids on hepatic mRNA levels of proteins regulating plasma lipoproteins in baboons with high and low levels of large high density lipoproteinsKUSHWAHA, R. S; ALEX MCMAHAN, C; MOTT, G. E et al.Journal of lipid research. 1991, Vol 32, Num 12, pp 1929-1940, issn 0022-2275Article

Measurement of very low density and low density lipoprotein apolipoprotein (apo) B-100 and high density lipoprotein apo A-I production in human subjects using deuterated leucine: effect of fasting and feedingCOHN, J; S;; WAGNER, D. A; COHN, S. D et al.The Journal of clinical investigation. 1990, Vol 85, Num 3, pp 804-811, issn 0021-9738Article

Equilibrium of apoproteins between high density lipoprotein and the aqueous phase: modelling of in vivo metabolismPONSIN, G; POWNALL, H. J.Journal of theoretical biology. 1985, Vol 112, Num 1, pp 183-192, issn 0022-5193Article

Post-heparin hepatic lipase activity and plasma high density lipoprotein levels in men during physical trainingSUTHERLAND, W. H. F; WOODHOUSE, S. P; NYE, E. R et al.Biochemical medicine. 1984, Vol 31, Num 1, pp 31-35, issn 0006-2944Article

High-density lipoprotein particles may regulate hemostasis in human pregnancyBELO, Luis; SANTOS-SILVA, Alice; LOWE, Gordon et al.Fertility and sterility. 2005, Vol 84, Num 4, pp 1021-1022, issn 0015-0282, 2 p.Article

The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humansSLOOP, G. D; GARBER, D. W.Clinical science (1979). 1997, Vol 92, Num 5, pp 473-479, issn 0143-5221Article

Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humansIKEWAKI, K; ZECH, L. A; KINDT, M et al.Arteriosclerosis, thrombosis, and vascular biology. 1995, Vol 15, Num 3, pp 306-312, issn 1079-5642Article